Clinical Trial Update: Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating phenethyl isothiocyanate for leukemia and other lymphoproliferative disorders was withdrawn. The sponsor was MD Anderson Cancer Cente…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoproliferative Disorders

Drugs mentioned

• Phenethyl Isothiocyanate (phenethyl isothiocyanate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoproliferative Disorders | Phase 1 | Status: WITHDRAWN